Daniel Tabet on Impacts of Nearly All Possible Missense Variants in the FH Gene LDLR
Daniel Tabet, Postdoctoral Research Associate at Broad Institute of MIT and Harvard, shared on LinkedIn:
”Big news!
Last week, our new study measuring the functional impacts of nearly all possible (~17k) missense variants in the FH gene LDLR was published as a First Release in Science Magazine—check it out!
This work, many years in the making, came together thanks to the many incredible scientists I’ve had the privilege of working alongside.
I’m enormously grateful to my co-first author, Atina Cote, who drove the experimental work with amazing creativity, and of course to my PhD mentor, Fritz Roth, who guided us through this project with clarity and vision.
A big thank you as well to Megan Lancaster, who pulled off the analysis in All of Us; to the many cardiologists and members of the CardioVar team (Calum MacRae, Dan Roden, Robert Hegele, Joshua Knowles, Euan Ashley, and many others) for a wealth of thoughtful guidance; and to members of the Roth Lab (most especially Jochen Weile) who were instrumental to this project.
So proud of how this came together and humbled to be part of such an outstanding team!”
Read the full article in Science.
Article: The functional landscape of coding variation in the familial hypercholesterolemia gene LDLR
Authors: Anna Axakova, Mafalda Bourbon, Jack M. P. Castelli, Victoria N. Parikh, Melina Claussnitzer, Atina G. Coté, Elizabeth T. Cirulli, Carmela Serio Carrero, Douglas M. Fowler, Iosifina Fotiadou, Michael Garton, Aanshi Gandhi, Andrew M. Glazer, Ranim Maaieh, Mohammad Majharul Islam, Kenneth Matreyek, Calum A. MacRae, Brett M. Kroncke, Da Kuang, Nishka Kishore, Joshua W. Knowles, Jennifer J. Knapp, Roujia Li, Megan C. Lancaster, Shahin Sowlati-Hashjin, Simon G. Pfisterer, Ashyad Rayhan, Dan M. Roden, Frederick P. Roth, Daniel Tabet, Olivia Taverniti, Jochen Weile, Euan A. Ashley, Robert A. Hegele
Stay updated on all scientific advances with Hemostasis Today.
-
Nov 4, 2025, 09:26Courtney Lawrence: One of Our Most Popular American Red Cross SUCCESS Talks is Just Around the Corner!
-
Nov 4, 2025, 09:21New Study by Emmanuel J Favaloro and Team Questions Consistency in APS Classification and Diagnosis
-
Nov 4, 2025, 09:20Yazan Abou Ismail to Present Insights on AI Models in TTP at 67th ASH Annual Meeting
-
Nov 4, 2025, 09:17David Calvet Canut on Takeda's HyHub: A Shift Toward Patient-Centered Biologics
-
Nov 4, 2025, 09:16Samantha Nelson Encourages You to Share Your Experience on World Thrombosis Day
-
Nov 4, 2025, 08:57Toluwalase Awoyemi: Digital Health Meets Maternal Heart Care
-
Nov 4, 2025, 08:53Rebecca Ahrens Nicklas Shares FDA Interactions on Interventional Genetics with The Rare Disease Community
-
Nov 3, 2025, 09:13Claudio Carrubba on How Timing Truly Matters in Trauma Embolization
-
Nov 3, 2025, 08:57Multiplex Apolipoprotein Panel Boosts Cardiovascular Risk Prediction and Precision Therapy
-
Nov 3, 2025, 08:46Rachel Lamerton and Colleagues on Activation of Platelets in Flow Cytometry
-
Nov 4, 2025, 09:10OCCUPI Trial Analysis Highlights Benefits of OCT Guidance in ACS Patients
-
Oct 29, 2025, 07:31The Use of Artificial Intelligence to Improve Detection of Acute Incidental Pulmonary Emboli - JTH
-
Oct 29, 2025, 07:05Shrinidhi Nathany: AI in Diagnostic Medicine
-
Oct 28, 2025, 07:02Aya Berman: AI Model for Predicting Bacteremia
-
Oct 28, 2025, 06:55The New Era of Genomics, AI and Cell Therapy in Hematology and Infectious Diseases
-
Nov 4, 2025, 09:17HaemophiliaIRL Series Begins․ Advances in von Willebrand Disease Treatment
-
Nov 4, 2025, 09:14Exploring Molecular Pathways of Aging in Hematopoiesis․ FEBS Workshop 2025
-
Nov 4, 2025, 08:28Fritz Roth Thanks Supporters of Science Magazine Study Linking Genes to High Cholesterol and Heart Attack Risk
-
Nov 4, 2025, 08:22Colleen Silk on Novo Nordisk Taking the 2025 Prix Galien US Award
-
Nov 4, 2025, 08:14Cristina Anton: Excited to Be Part of Women in Hematology!